These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 15869569)
21. Clinical consequences of antiphospholipid antibodies. Derksen RH; de Groot PG Neth J Med; 2004 Sep; 62(8):273-8. PubMed ID: 15588067 [TBL] [Abstract][Full Text] [Related]
22. The antiphospholipid and thrombosis syndromes. Bick RL; Baker WF Med Clin North Am; 1994 May; 78(3):667-84. PubMed ID: 8170264 [TBL] [Abstract][Full Text] [Related]
23. [Abdominal pain in a pregnant 34-year-old woman]. Josse S; Benhamou Y; Girault C; Lecam-Duchez V; Provost D; Verspyck E; Piquenot JM; Lévesque H; Queyrel V Rev Med Interne; 2011 Apr; 32(4):255-60. PubMed ID: 21296468 [No Abstract] [Full Text] [Related]
24. [Phospholipid antibodies (lupus anticoagulant and cardiolipin antibodies). Detection and clinical significance]. Wisløff F; Sletnes KE; Schjetlein R Tidsskr Nor Laegeforen; 1993 Aug; 113(18):2269-72. PubMed ID: 8362396 [TBL] [Abstract][Full Text] [Related]
25. Update on anti-phospholipid antibodies in SLE: the Hopkins' Lupus Cohort. Petri M Lupus; 2010 Apr; 19(4):419-23. PubMed ID: 20353980 [TBL] [Abstract][Full Text] [Related]
28. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics. Cervera R; Asherson RA Immunobiology; 2005; 210(10):735-41. PubMed ID: 16325491 [TBL] [Abstract][Full Text] [Related]
29. Lupus anticoagulant and anticardiolipin antibodies in serum of patients treated with risperidone. Schwartz M; Kormilachev M; Kushnir M; Weller B; Rochas M; Toubi E J Clin Psychiatry; 2009 May; 70(5):769-71. PubMed ID: 19552873 [No Abstract] [Full Text] [Related]
30. [Antiphospholipid antibodies as risk factor for venous thromboembolism]. Windyga J Pol Arch Med Wewn; 2002 Nov; 108(5):1065-70. PubMed ID: 12685247 [TBL] [Abstract][Full Text] [Related]
31. Induction of anticardiolipin antibody and/or lupus anticoagulant in rabbits by immunization with lipoteichoic acid, lipopolysaccharide and lipid A. Gotoh M; Matsuda J Lupus; 1996 Dec; 5(6):593-7. PubMed ID: 9116702 [TBL] [Abstract][Full Text] [Related]
32. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Galli M; Luciani D; Bertolini G; Barbui T Blood; 2003 Mar; 101(5):1827-32. PubMed ID: 12393574 [TBL] [Abstract][Full Text] [Related]
33. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications. Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474 [TBL] [Abstract][Full Text] [Related]
34. Acquired hypoprothrombinemia related to high titres of antiprotein-phospholipid antibodies. de Larrañaga G; Forastiero R; Carreras LO; Zala N; Guzman L; Alonso B Thromb Haemost; 1999 Feb; 81(2):317-8. PubMed ID: 10064016 [No Abstract] [Full Text] [Related]
35. Precision medicine and the antiphospholipid syndrome: what is the future? Rodriguez-Pintó I; Espinosa G; Cervera R Clin Rheumatol; 2020 Apr; 39(4):1015-1017. PubMed ID: 32060811 [No Abstract] [Full Text] [Related]
36. Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy. Gkrouzman E; Barbhaiya M; Erkan D; Lockshin MD Arthritis Rheumatol; 2021 Jan; 73(1):173-174. PubMed ID: 32901454 [No Abstract] [Full Text] [Related]